r This study assessed the respective contributions of haematological and skeletal muscle adaptations to any observed improvement in peak oxygen uptake (V O 2 peak ) induced by endurance training (ET).
Introduction
Endurance training (ET) prompts multiple physiological adaptations that may all lead to increased peak oxygen uptake (V O 2 peak ) in healthy humans (Clausen, 1977; Klausen et al. 1982; Saltin, 1985; Beere et al. 1999; Nottin et al. 2002; Daussin et al. 2007; Murias et al. 2010; Jacobs et al. 2013b; Bonne et al. 2014) . These adaptations must enhance oxygen delivery to and/or extraction and utilization by metabolic active tissue in order to increasė V O 2 peak . Indeed, ET has been associated with central adaptations such as improved heart function/structure (Baggish et al. 2008) , increased plasma and red blood cell volume (RBCV) (Sawka et al. 2000; Bonne et al. 2014) as well as peripheral adaptations resulting in decreased vascular resistance (Klausen et al. 1982; Weng et al. 2013) , all of which may enhance peak cardiac output (Q peak ) and thereby oxygen delivery. Moreover, peripheral adaptations to ET comprising increases in skeletal muscle capillarization (Murias et al. 2011) , mitochondrial content/function (Hoppeler et al. 1973 Jacobs et al. 2013b; Jacobs & Lundby, 2013 ) and a more efficient blood flow distribution (Kalliokoski et al. 2001) could improve oxygen extraction and utilization. Nevertheless, the relative contribution of the above adaptations to the improvement inV O 2 peak following ET remains uncertain despite related research spanning over four decades (Ekblom et al. 1968; Saltin et al. 1968 ). In addition, there seems to be a distinct progression of central and peripheral adaptations throughout ET (Murias et al. 2010) . In this respect, 2-3 weeks of high-intensity interval or moderate ET induced increases inV O 2 peak that were mostly dependent on peripheral adaptations enhancing oxygen extraction in untrained subjects (Murias et al. 2010; Jacobs et al. 2013b) . On the other hand, the increase inV O 2 peak following 6 weeks of moderate ET reverted to the baseline level after removing the ET-induced gain in blood volume (BV) in untrained subjects , which would suggest a predominant role for haematological adaptations. However, peripheral adaptations were not determined in the latter study . Furthermore, increased peak oxygen extraction was reported in studies assessing ET interventions lasting more than 2 weeks in untrained subjects (Spina et al. 1992; Beere et al. 1999; Murias et al. 2010) . Therefore, it is unclear to what extent peripheral adaptations to ET influenceV O 2 peak once central adaptations have taken place.
To address this question, we assessed central (haematological) and peripheral (skeletal muscle) adaptations, all relating to either the delivery or extraction/utilization of oxygen, along withV O 2 peak anḋ Q peak before and after 6 weeks of moderate ET in untrained healthy young subjects. After the post-ET assessment, RBCV was re-established at the pre-ET level by phlebotomy, so as to offset haematological adaptations to ET while skeletal muscle adaptations remained intact, andV O 2 peak andQ peak were determined again. We hypothesized that the improvement inV O 2 peak following 6 weeks of ET would be primarily explained by haematological adaptations leading to increased oxygen delivery in untrained healthy young subjects.
Methods

Ethical approval
The study was approved by the Ethical Committee of the Eidgenössische Technische Hochschule Zürich (EK 2011-N-51) and conducted in accordance with the standards set by the Declaration of Helsinki. Prior to the start of the experiments, informed oral and written consents were obtained from all participants.
Subjects
Sixteen previously untrained healthy male volunteers (age = 25.3 ± 4.1 years, body weight = 76.4 ± 8.7 kg, height = 179.9 ± 8.3 cm,V O 2 peak = 3.5 ± 0.5 l min −1 ) were recruited as study subjects. All subjects were non-smokers and none were taking medication during the study.
Study design
The measures described below were assessed under non-fasting conditions at baseline (pre-ET) and after 6 weeks (post-ET) of ET. In addition, 2-3 days after post-ET, measures related to the incremental exercise test and haematology were determined immediately (10 min) after phlebotomy.
Phlebotomy
The ET-induced increase in RBCV was reset to pre-training values by means of phlebotomy. The amount of whole blood to be withdrawn was estimated (on the basis of the Hct) to result in a RBCV loss that counterbalanced (±50 ml) the gain in RBCV with ET for each individual subject. For this purpose, a 20 G venflon (BD, USA) was placed in an antecubital vein and the blood was withdrawn and discarded. The subjects then rested for 10 min in the supine position and subsequently initiated the incremental exercise test.
Exercise training
All subjects underwent 6 weeks of supervised ET consisting of 60 min of cycle ergometer exercise. Subjects performed three or four training sessions/week over this period. Three different intensity profiles were alternated to facilitate participant motivation and compliance. Profile 1 consisted of a steady-state exercise, i.e. 60 min at 65% of peak power output (Ẇ peak ) attained with the incremental exercise test. Profile 2 started with 3 min at 50% ofẆ peak followed by 3X60, 3X65, 3X70, 3X75, 3X70, 3X65, 3X60, 3X50, 3X65, 3X50, 3X60, 3X65, 3X70, 3X75, 3X70, 3X65, 3X60, 3X50 and 3X65. Profile 3 started with 6 min at 65% ofẆ peak followed by 4X75, 6X65, 4X75, 6X65, 4X75, 6X65, 4X75, 6X65, 4X75, 6X65 and 4X75. Workloads were calculated from individual W peak determined during the incremental exercise test at baseline. Exercise intensity was on average 65% ofẆ peak .
Measurements
Incremental exercise test.Ẇ peak andV O 2 peak were determined on an electronically braked bicycle ergometer (Monark, Sweden) with continuous measurements oḟ V O 2 using an online gas collection system (Innocor M400, Innovision, Denmark). The test started with a warm-up period of 5 min at 50-150 W workloads. Thereafter, the workload was increased by 30 W every 60-90 s until exhaustion. The gas analysers and the flowmeter of the applied spirometer were calibrated prior to each test. Breath-by-breath values were averaged over 30 s. The highest average value was taken as thė V O 2 peak provided that standard criteria were fulfilled (American Thoracic Society, 2003) .Ẇ peak was calculated asẆ compl + 30 × (t/90);Ẇ compl is the last fully completed workload and t is the number of seconds in the final workload. To evaluate cycling economy,V O 2 was determined during submaximal cycling. In this regard, breath-by-breath values during warm-up (100 W) were averaged.
Cardiac output was measured by an inert gas re-breathing technique (Innocor M400). The method has been described and validated (Siebenmann et al. 2014) . Briefly, the measurement is based on the assumption that pulmonary uptake of a blood soluble testing gas is proportional to pulmonary blood flow (Krogh & Lindhard, 1912) . The Innocor uses a test gas mixture containing 5% nitrous oxide (N 2 O, soluble in blood and physiologically inert), 1% of the insoluble sulphur hexafluoride and 94% oxygen. This is filled, together with ambient air, into the re-breathing bag before the onset of a measurement. The volume of the re-breathing bag is predetermined according to the tidal volume to allow for unrestricted ventilation. When a measurement is initiated, the subject is switched from breathing room air to the closed circuit and re-breaths the testing gas. In the present study, re-breathings were separated by several minutes with the intent to limit confounding effects related to re-circulating inert gas (Siebenmann et al. 2014) . Pulmonary N 2 O uptake was determined by a regression line over the N 2 O concentration curve in three consecutive expirations as soon as complete mixture was obtained between residual pulmonary air and the gas in the re-breathing bag. Subjects were familiarized with the re-breathing technique through two familiarization tests and further conducted two or three practice procedures before each test.Q peak was assessed during incremental exercise with the re-breathing procedure initiated five heart rate beats below the previously assessed maximal heart rate. The peak arteriovenous oxygen difference (a-vO 2diff ) was calculated from the Fick equation (a-vO 2diff =V O 2 peak /Q peak ).
Blood. Haemoglobin mass (Hb mass ) was measured as previously described , using a modified version of the carbon monoxide (CO) re-breathing technique (Burge & Skinner, 1995) . All subjects rested for 20 min in a semi-recumbent position before each measurement. Thereafter, 2 ml of blood was sampled from an antecubital vein via a 20 G venflon (BD, USA) and analysed immediately in quadruplicate J Physiol 593.20 for (i) percentage carboxyhaemoglobin (%HbCO) and Hb concentration ([Hb] ) using a haemoximeter (ABL800, Radiometer, Denmark), and (ii) haematocrit (Htc) with the micromethod (4 min at 13,500 rpm). Subsequently, the subject breathed 100% oxygen for 4 min to flush the nitrogen from the airways. After closing the oxygen input, a bolus 1.5 ml kg −1 of 99.997% chemically pure CO (CO N47, Air Liquide, France) was administrated into the breathing circuit. The subjects re-breathed this gas mixture for 10 min. Then, an additional 2 ml blood sample was obtained and analysed in quadruplicate. The change in%HbCO was used to calculate Hb mass , taking into account the amount of CO that remained in the re-breathing circuit at the end of the procedure (2.2%) (Burge & Skinner, 1995) . Total RBCV, BV and plasma volume (PV) were derived from measures of Hb mass and haematocrit (Burge & Skinner, 1995) .
Skeletal muscle biopsy. Using the Bergström technique (Bergstrom, 1962 ) with a needle modified for suction, skeletal muscle biopsies from m. vastus lateralis were obtained under local anaesthetics while the subject was at rest with a minimum of 24 h following the last exercise training bout. The biopsy specimen was dissected free of fat and connective tissue, divided into sections and immediately prepared for analysis as stated below.
Fibre typing. Muscle samples were embedded in Tissue Tek (Sakura Finetek, USA) and serial transverse sections of10-12 µm (Leica CM 1850, Leica Biosystems, Germany) were used for histochemical analysis. A myofibrillar ATPase reaction was carried out at pH 9.4. By applying pre-incubations at pH 4.3, 4.6, and 10.3, the fibres were classified as slow twitch type I (ST), fast twitch type IIa (FTa) and type IIx (FTx) (Brooke & Kaiser, 1970; Gollnick et al. 1972) . A slide scanner (Zeiss Mirax Midi, Germany) connected to a 3-CCD colour camera (Hitachi HV-F22(1360 × 1024 pixels), Japan) was used for digitizing the cryo-sections at a ×20 magnification and further analysed by using the free version of Panoramic viewer (3DHISTECH Ltd, Hungary). The relative occurrence of fibre types for each subject was determined from a mean of 207 ± 117 (range 79-729) fibres. Fibre typing was not conducted in four subjects due to poor tissue preparation.
Muscle capillarization. Serial transverse sections (8 µm) prepared as described above were used for immunohistochemical analysis for capillary density. Primary antibodies against caveolin-1 (Cat 610060) and collagen IV (Dako M0785) in conjunction with biotinylated secondary antibodies (Dako E032 and E033) and the VECTASTAIN ABC-AP KIT (Vector laboratories, USA) were used for capillary identification. Sections were visualized as described above. Capillary density was determined by counting the number of capillaries surrounding a minimum of 50 coherent fibres and expressed as the capillary-to-fibre ratio. Counting was performed manually using Photoshop CS6 and Panoramic Viewer (3DHISTECH Ltd). The number of capillaries in the outer circumference of each section was divided by 2 and then added to the number of capillaries in the inner section. The total number of capillaries was divided by the number of counted fibres. Capillary-to-fibre ratio was missing for six subjects due to poor tissue preparations.
Mitochondrial volume density. Four 1 mm 3 pieces of each muscle biopsy were fixed in 2.5% glutaraldehyde at RT and processed according to standard electron-microscopy protocols. TEM images were obtained in a FEI Tecnai G2 Spirit electron microscope (FEI, USA) with an Orius SC1000 CCD camera (Gatan, USA) and interfaced with the TEM User software from FEI. Two hundred and sixteen images per biopsy were acquired in a random systematic order from 24 meshes distributed on 8 grids from 4 blocks. The Cavalieri feature in the Stereo-Investigator software (MBF Bioscience, USA) was used to estimate mitochondrial volume density (Mito VD ) by point counting (West, 2012) The grid spacing was 1 µm along both x-and y-axis. Mitochondria boundaries were recognized at the ×8200 magnification. Each point was assigned as either intermyofibrillar (IMF) mitochondria, subsarcolemmal (SS) mitochondria, muscle or 'nothing' . SS mitochondria were defined as the mitochondria that were not separated by myofibrils from the sarcolemma. Mito VD determinations were not performed in three subjects due to lack of tissue.
Mitochondrial respiration. For analysis of oxidative phosphorylation a piece of the biopsy (ß20 mg) was placed in an ice-cold biopsy preservation solution (BIOPS) and processed as previously described (Jacobs et al. 2013b) . Measurements of oxygen consumption for the evaluation of oxidative phosphorylation capacity (OXPHOS) and electron transfer capacity (ETS) were performed in duplicate at 37°C and in a hyperoxygenated environment using the high-resolution Oxygraph-2k (Oroboros, Austria) previously described in detail (Jacobs et al. 2013b) . A more complete listing of and thorough explanations for the standard nomenclature regarding various respiratory states, titration protocols, coupling control and flux control ratios can be found elsewhere Jacobs et al. 2013b) . Mitochondrial respiration measures were missing for two subjects.
Hexokinase and lactate dehydrogenase enzyme content.
Snap frozen muscle sections were freeze dried for 16 h at −55°C (ScanVac CoolSafe55-4, Denmark), thereafter homogenized (Precellys 24 Tissue Homogenizer, Bertin Technologies, France) and prepared as previously described . Total protein concentrations were determined by BCA assay (Pierce, USA). Standard western blotting procedures (Jacobs et al. 2013a) were applied for quantification of hexokinase II (2867S, Cell Signalling Technology, USA) lactate dehydrogenase (ab135396, Abcam, UK) and actin (A2066, Sigma Aldrich, USA) detection. Protein bands were detected with LuminataTM Classico (Millipore, USA) using the Las-4000 image analyser system (Fujifilm Life Science, USA). Quantification of band intensity was done using Image J software (NIH, USA) and determined as the total band intensity minus the background intensity. The primary antibodies were optimized by use of a pool of human muscle lysates. Pre-and post-samples were loaded on the same gel. Signal intensity from each muscle sample was normalized to the mean signal intensity of all samples on the same gel.
Statistical analysis
The paired Student's t test and Wilcoxon signed-rank test were respectively used to assess normally and non-normally distributed differences between pre-ET, post-ET and phlebotomy pairs. Bivariate associations were determined by Pearson's correlation coefficients. A stepwise multiple regression analysis was used to identify variables independently associated withV O 2 peak . Variables significantly associated withV O 2 peak in bivariate analysis were entered into the regression model as independent variables. Additionally, multiple regression analyses forcing the inclusion of potential causative variables (Q peak , haemotological variables, capillary-to-fibre ratio, total Mito VD , ST cross-sectional area) based on established underlying physiology (di Prampero & Ferretti, 1990; Bassett & Howley, 2000; Levine, 2008) were performed. In the event of high correlation between independent variables, each of these were separately entered into the regression model in order to avoid high multicollinearity (variance inflation factor (VIF) > 10). A two-tailed P value less than 0.05 was considered significant. Variables were expressed as means ± SD, unless otherwise stated. All statistical analyses were performed using MedCalc software (bvba, Mariakerke, Belgium).
In addition, an intuitive approach using mean effects and confidence intervals was used to assess mechanistic magnitude-based inferences (Hopkins, 2007; Hopkins et al. 2009 ). Such an approach determines the effect as unclear if the confidence interval, which represents uncertainty about the true value, overlaps values that are substantial in a positive and negative sense as regards the smallest physiologically worthwhile effect; otherwise, the effect is characterized with a qualitative statement about the chance that it is positive or negative. In order to limit the potential experimenter's bias, any mean effect distinct from the zero value was considered as a physiologically worthwhile effect. The qualitative probabilistic terms are assigned following the following scale (Hopkins, 2007; Hopkins et al. 2009 ): most unlikely, < 0.5%; very unlikely, 0.5-5%; unlikely, 5-25%; possibly, 25-75%; likely, 75-95%; very likely, 95-99.5%; and most likely, > 99.5%, all of them referred to a given positive or negative effect.
Results
All subjects completed 18-20 endurance exercise sessions over the 6 week intervention period. Body weight was unchanged by ET.
Incremental exercise test (Table 1) W peak was increased (P < 0.05) by 42 ± 31 W (16 ± 13%) from pre-to post-ET and was reduced (P < 0.05) by 16 ± 13 W (5 ± 4%) following the phlebotomy procedure when compared with post-ET. Compared with pre-ET,Ẇ peak remained 26 ± 23 W (10 ± 10%) higher (P < 0.05) after the phlebotomy. V O 2 peak was increased (P < 0.05) by 0.32 ± 0.30 l min −1 (9 ± 8%) from pre-to post-ET and reduced (P < 0.05) by 0.24 ± 0.26 l min −1 (7 ± 7%) with phlebotomy compared with post-ET. There was no difference inV O 2 peak between pre-ET and after the phlebotomy procedure. Q peak was enhanced (P < 0.05) by 1.26 ± 1.09 l min −1 (7 ± 6%) from pre-to post-ET and reduced (P < 0.05) by 1.74 ± 1.02 l min −1 (10 ± 7%) following phlebotomy compared with post-ET. There was no difference inQ peak between pre-ET and after the phlebotomy procedure. The calculated peak a-vO 2diff was not altered by ET. After phlebotomy, peak a-vO 2diff was increased compared to pre-ET (P < 0.05) but not with respect to post-ET. Cycling economy, determined by the averageV O 2 during the 100 W workload remained unchanged throughout the study. Magnitude-based inferences determined the above significant differences as 'most likely' , except for that regarding peak a-vO 2diff which was deemed 'very likely' .
Haematological adaptations (Table 1) ET resulted in 187 ± 94 (8 ± 4%), 123 ± 188 (4 ± 6%) and 310 ± 258 ml (6 ± 5%) increases (P < 0.05) in RBCV, PV and BV, respectively. The phlebotomy procedure normalized RBCV to the pre-ET level and at the same time induced 186 ± 133 ml and 359 ± 198 ml respective decreases (P < 0.05) in PV and BV (i.e. very mild hypovolaemia) compared with post-ET. Therefore, after phlebotomy PV and BV were 63 ± 103 (2 ± 4%) and 49 ± 111 ml (1 ± 2%) lower (P < 0.05 only Values are means ± SD. Skeletal muscle adaptations were measured in a subgroup of the total sample (n<16). * , † and ‡ denote statistical significant differences (P < 0.05) from pre to post, post to phlebotomy and pre to phlebotomy, respectively. BV, blood volume; ETS, electron transport system capacity in skeletal muscle; FTa, fast twitch type IIa muscle fibre; FTx, fast twitch type IIx muscle fibre; [Hb] , haemoglobin concentration; Hb mass , haemoglobin mass; Hct, haematocrit; IMF, intermyofibrillar; Mito VD , mitochondrial volume density; OXPHOS, maximal oxidative phosphorylation capacity in skeletal muscle; PV, plasma volume;Q peak , peak cardiac output; RBCV, red blood cell volume; SS, subsarcolemmal; ST, slow twitch type I muscle fibre;V O 2 peak , peak oxygen uptake;Ẇ peak , peak power output.
for PV) than pre-ET. Hb mass was enhanced (P < 0.05) by 45 ± 40 g (6 ± 5%) after ET. Htc was increased (P < 0.05) by 0.92 ± 1.12% (2 ± 3%) from pre-to post-ET and remained higher (P < 0.05) after phlebotomy when compared with pre-ET.
[Hb] did not change as a function of ET or phlebotomy. The above significant differences ranged from 'very likely' to 'most likely' according to magnitude-based inferences.
Skeletal muscle adaptations (Table 1) Capillary-to-fibre ratio was increased (P < 0.05) by 0.28 ± 0.28 (18 ± 16%) from pre-to post-ET. Total, SS and IMF Mito VD were increased (P < 0.05) by 1.82 ± 0.96 (43 ± 30%), 0.70 ± 0.63 (184 ± 328%) and 1.12 ± 0.82% (35 ± 40%) from pre-to post-ET, respectively. OXPHOS and ETS did not change in absolute terms but were decreased (P < 0.05) by 18 ± 28 and 20 ± 20% when normalized to total Mito VD following ET. Regarding muscle fibre types, ST cross-sectional % area was decreased (P < 0.05) by 7.92 ± 10.12% (13 ± 19%) while FTx cross-sectional % area was increased (P < 0.05) by 4.36 ± 4.62% (140 ± 240%) after ET. FTa muscle fibre cross-sectional area was not modified by ET. Muscle hexokinase and lactate dehydrogenase protein content were not modified by ET. The above significant differences ranged from 'very likely' to 'most likely' according to magnitude-based inferences. withV O 2 peak . In addition, peripheral variables potentially affecting oxygen extraction such as capillary-to-fibre ratio, total Mito VD and OXPHOS were not correlated with peak a-vO 2diff (r = 0.02, P = 0.93; r = 0.11, P = 0.60; r = −0.24, P = 0.21, respectively).
Bivariate associations
Multiple regression analysis
All variables significantly associated withV O 2 peak in bivariate analysis were entered into a stepwise multivariable regression model to determine the independent predictors ofV O 2 peak (Table 3) . RBCV, PV BV and Hb mass were closely correlated with each other in bivariate analysis (r > 0.85, P < 0.0001) and their concurrent inclusion in multiple regression analysis resulted in a VIF > 10, indicating high multicollinearity. Accordingly, each of the aforementioned haematological variables were separately entered into the regression model.Q peak , Hct, ST cross-sectional % area, FTa cross-sectional % area and PV, RBCV, BV or Hb mass were entered into the regression model as potential independent predictors ofV O 2 peak .Q peak remained the only independent predictor ofV O 2 peak when PV or BV were included in the regression model (adjusted R 2 = 0.65, P < 0.0001). Moreover, RBCV was the only independent predictor ofV O 2 peak when RBCV was included in the regression model (adjusted R 2 = 0.74, P < 0.0001). Finally, Q peak along with Hb mass were the independent predictors ofV O 2 peak when Hb mass was included in the regression model (adjusted R 2 = 0.73, P < 0.0001). In addition, potentially causative variables according to accepted underlying physiology were forced into multiple regression models withV O 2 peak as the dependent variable. Following this approach, the highly inter-correlated haematological variables (RBCV, PV, BV and Hb mass ) were the independent predictors ofV O 2 peak .
Discussion
This study assessed the respective role of central and peripheral adaptations onV O 2 peak following 6 weeks of ET and subsequent phlebotomy in previously untrained healthy young subjects. As expected, ET led to increases in RBCV, PV, Hb mass , Htc, skeletal muscle capillarization and Mito VD , as well as enhancedQ peak andV O 2 peak . The key observations were: (i)Q peak andV O 2 peak , but notẆ peak , were normalized to pre-ET levels when the ET-induced increase in RBCV was abolished by means of phlebotomy and (ii) oxygen delivery-related variables such asQ peak , RBCV, BV and Hb mass were independent predictors oḟ V O 2 peak .
Accumulating evidence corroboratesQ peak as the main factor contributing to the increase inV O 2 peak after 5-13 weeks of ET in untrained/moderately trained healthy young humans (Klausen et al. 1982; Spina et al. 1992; Helgerud et al. 2007; Murias et al. 2010; Weng et al. 2013; Bonne et al. 2014; Wang et al. 2014 ). In the current study, the concomitant increase ofQ peak , RBCV andV O 2 peak with 6 weeks of ET, and subsequent reversal with phlebotomy supports a major role of oxygen delivery onV O 2 peak . Moreover, the ET-induced increase inV O 2 peak (ß320 ml) was accompanied by a lower than predicted Hb mass gain (ß45 g), considering the proposed 4 ml min −1 increase inV O 2 peak per 1 g rise in Hb mass (Schmidt & Prommer, 2010) . This highlights the impact of the increase ofQ peak on oxygen delivery after ET. Given that both central and peripheral adaptations to ET may influenceQ peak (Klausen et al. 1982; Calbet et al. 2006; Baggish et al. 2008; Weng et al. 2013; Bonne et al. 2014) , it could be questioned whether the increase in oxygen delivery was led by central adaptations alone or along with peripheral adaptations. The fact that the increase inQ peak was abolished after RBCV (and BV) normalization strongly suggests that haematological adaptations to 6 weeks of ET primarily underlay the increase in oxygen delivery J Physiol 593.20 andV O 2 peak , which was confirmed in multiple regression analysis. Nonetheless, whilst speculative, it is possible that after phlebotomy an increase in sympathetic activation due to moderate hypovolaemia (Fortrat et al. 1998; Zollei et al. 2004) may have masked a possible decrease in vascular resistance at peak exercise which would contribute as a peripheral adaptation to the increase inQ peak andV O 2 peak following ET (Klausen et al. 1982; Weng et al. 2013) . The erythropoietic response to ET merits particular attention. Although debated two decades ago (Shoemaker et al. 1996) , it is currently accepted that ET facilitates RCBV expansion (Schmidt & Prommer, 2010) . According to the present and preceding reports, RBCV may be enhanced by 8-13% after 6-12 weeks (Warburton et al. 2004; Helgerud et al. 2007; Bonne et al. 2014) and longer (Sawka et al. 2000; Schmidt & Prommer, 2008) normoxic ET interventions in previously un-to moderately trained subjects. Yet, the mechanisms stimulating erythropoiesis with exercise training remain unclear. In this regard, the expression of hypoxia-inducible factor-2 was transiently increased in untrained skeletal muscle in response to acute exercise and returned to pre-exercise values after 24 h of recovery , while plasma erythropoietin concentration is increased (Schwandt et al. 1991) or unchanged (Schmidt et al. 1991; Weight et al. 1992; Bodary et al. 1999) up to 24-48 h following acute exercise in un-and trained subjects. In the longer term, the increase in PV relative to RBCV within the first few days of ET might propel the erythropoietic system to approach a new equilibrium in that haematocrit is re-established at the pre training level (Sawka et al. 2000; Schmidt & Prommer, 2008; Jelkmann & Lundby, 2011) . Herein, the observation of increased haematocrit after 6 weeks of ET suggests that the early RBCV expansion might be, at least in part, non-hypoxically regulated. Alternatively or additionally to hypoxia-related signals, Bars represent mean ± SEM. * P < 0.05. RBCV, red blood cell volume;V O 2 peak , peak oxygen uptake;Ẇ peak , peak power output.
post-exercise reduced central venous pressure (Halliwill et al. 2000) might contribute to upregulate erythropoietin production (Gunga et al. 1996) . Furthermore, exercise may alter the circulating levels of catecholamines, peptides (growth hormone, insulin-like growth factor) and steroid hormones (testosterone, cortisol) known to modulate red blood cell production and/or release from the bone marrow (Hu & Lin, 2012) . Skeletal muscle adaptations to the 6 week ET were observed (Table 1) . Capillary-to-fibre ratio and Mito VD were increased by 18 and 43%, respectively, but were not associated withV O 2 peak . Earlier reports have shown comparable increases in muscle capillarization and Mito VD after 6 weeks of ET Turner et al. 1997) , which, however, were associated withV O 2 peak in a group of 10 untrained young men and women . Differences in methodology, sample size and gender distribution might account for the discrepancy in theV O 2 peak associations. Besides, it should be noted that, in the present study, skeletal muscle OXPHOS was similar prior to and after ET, which is consistent with findings from 6 week ET interventions in young men (Ponsot et al. 2006; Robach et al. 2014) but contrasts with studies demonstrating increased skeletal muscle OXPHOS in shorter-(2 weeks) and longer-term (ࣙ10 weeks) endurance-trained male subjects Jacobs et al. 2013b; Jacobs & Lundby, 2013) . Likewise, oxygen extraction, as determined by a-vO 2diff , was increased following ET interventions lasting 2-3 and 12-13 but not 5-8 weeks in young (primarily male) subjects (Klausen et al. 1982; Spina et al. 1992; Beere et al. 1999; Helgerud et al. 2007; Murias et al. 2010; Jacobs et al. 2013b; Weng et al. 2013; Bonne et al. 2014; Wang et al. 2014 ), including the current findings. Thus, the unchanged oxygen extraction could be paralleled, not necessarily caused (Boushel et al. 2011) , by the transitory normalization of OXPHOS in skeletal muscle in the presence of increased oxygen delivery within the 5 to ß8 week period of ET. On the other hand, the enhanced muscle capillarization might prevent a decrease in oxygen extraction after ET if oxygen diffusion is hampered by an increase in capillary blood flow velocity associated with that ofQ peak (Spurway et al. 2012) . In addition, we found a positive association between ST muscle fibre cross-sectional % area andV O 2 peak , even though, paradoxically, the ST cross-sectional % area was decreased whereas FTx cross-sectional % area was increased after ET. This could suggest that the FTx cross-sectional absolute area was increased with ET provided that leg muscle mass is, if anything, augmented following ET in healthy young subjects (Spence et al. 2013) , corresponding with the notion that the increase in fast-twitch fibre size occurs during the first 8 weeks of ET while slow-twitch fibres are increased after 8-24 weeks of ET (Abernethy et al. 1990 ). Taken together, the impact of skeletal muscle adaptations (measured in this study) onV O 2 peak may be dynamically related to the duration of ET.
It should be noted that peak a-vO 2diff was higher following phlebotomy than prior to ET. As previously mentioned, it could be speculated that the phlebotomy-induced decrease inQ peak and plausible lower leg blood flow, along with the increase in muscle capillarization, may have augmented red blood cell transit time and thus peak a-vO 2diff . However, the lack of association between peak a-vO 2diff and capillary-to-fibre ratio (r = 0.02, P = 0.93), even when adjusted forQ peak (r = 0.09, P = 0.73), weakens this hypothesis. Likewise, this speculation conflicts with the existence of a considerable reserve in muscle O 2 diffusing capacity in normoxia in healthy individuals (Calbet et al. 2003 (Calbet et al. , 2009 ). Alternatively, the higherẆ peak, but similarQ peak , following phlebotomy compared with pre-ET -if these reflect an increase in exercise intensity relative to leg O 2 delivery -could lead to enhanced peak a-vO 2diff (Richardson et al. 1993) . In this respect, peak a-vO 2diff correlated with theẆ peak -to-Q peak ratio (r = 0.41, P = 0.004) in the present study. Additionally, oxygen extraction might be augmented via improved blood flow distribution (Heinonen et al. 2013) related to the increase in sympathetic drive prompted by phlebotomy (Fortrat et al. 1998; Zollei et al. 2004) .
The effects of phlebotomy onV O 2 peak and peak power output during incremental exercise (Ẇ peak ) were dissociated in thatV O 2 peak was normalized butẆ peak remained increased compared to pre-ET levels (Fig. 1) . Hence, the increase inẆ peak after ET was not exclusively driven by the improved aerobic capacity, as previously suggested (Jacobs et al. 2011) . Additional adaptations potentially underlying the increase inẆ peak after training include, but are not limited to, changes in biochemical and neuromuscular factors (Noakes, 1988; Paavolainen et al. 1999) . With regard to the former, the increase inẆ peak after ET could be secondary to, among other things, an enhanced muscle buffering capacity (Weston et al. 1997) associated with the increase in FTx cross-sectional area (Nakagawa & Hattori, 2002) . In turn, we did not detect an increase in muscle hexokinase and lactate dehydrogenase protein content after ET. Ultimately, submaximal cycling economy was not modified by ET, although evidence for this is lacking at peak exercise.
Limitations
Findings were obtained from a relatively small number of untrained healthy young males, thus our conclusions should be taken with caution and limited to this population. Moreover, adaptations to ET related to vascular resistance were not assessed, and furthermore, the measured peripheral adaptations were not available in all study subjects, which might have reduced the J Physiol 593.20 statistical power to detect their influence onV O 2 peak . Nevertheless, equivalent results were found in a subgroup (n = 10) of the total sample with complete phenotyping. Also, the observed adaptations could be partly specific to the intensity, rather than the duration, of training that was applied (Daussin et al. 2007 (Daussin et al. , 2008 , though the contribution of the latter seems predominant in our study population (Murias et al. 2010) . Finally, despite RBCV being restored to the resting pre-ET level after phlebotomy, it is uncertain whether the normalization was preserved during exercise.
Conclusion
The effect of 6 weeks of ET onV O 2 peak is primarily explained by an increase inQ peak and oxygen-carrying capacity of blood in previously untrained healthy young subjects. Skeletal muscle adaptations related to muscle capillarization and mitochondrial volume density do not substantially contribute to theV O 2 peak improvement following 6 weeks of ET. Further research is needed to elucidate whether the predominant effect of haematological adaptations onV O 2 peak persists with longer term ET in healthy subjects.
